{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:07:48Z","timestamp":1792012068029,"version":"4.4.0"},"reference-count":55,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Reg Anesth Pain Med"],"accepted":{"date-parts":[[2025,9,23]]},"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Incomplete or inconsistent reporting of adverse events (AEs) undermines the interpretability of randomized trials. In interventional regional anesthesia (RA), where procedural risks must be clearly communicated, such discrepancies may obscure safety profiles. This study evaluates concordance between AE data reported in ClinicalTrials.gov and corresponding peer-reviewed publications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a systematic review of interventional RA trials registered on ClinicalTrials.gov with published results. AE data were extracted in duplicate across four domains: serious adverse events, other adverse events, treatment-related discontinuations, and all-cause mortality. Descriptive statistics characterized trial features. Bland\u2013Altman and funnel plots assessed reporting concordance and bias. \u03c7\n                      <jats:sup>2<\/jats:sup>\n                      tests compared reporting completeness by regulatory status. A composite 0\u20137 AE reporting score, derived from Food and Drug Administration Amendments Act Final Rule\u2013mandated fields, was analyzed using linear and segmented regressions to identify predictors of reporting and temporal trends.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among included trials, substantial discrepancies were observed in AE counts between ClinicalTrials.gov and publications. Funnel plot asymmetry suggested possible underreporting in smaller studies. Trials subject to FDA reporting requirements were significantly more likely to report complete AE data (p&lt;0.05). Composite AE reporting scores were higher in industry-sponsored and drug-focused trials. Segmented regression identified a modest post-Final Rule increase in reporting completeness, though recent-year instability limits interpretation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>In RA trials, AE reporting is frequently incomplete or discordant across sources, with regulatory oversight linked to greater transparency. These findings highlight the need for standardized safety reporting and alignment between registries and publications to ensure accurate risk communication in anesthesiology research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/rapm-2025-107055","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T08:20:14Z","timestamp":1760084414000},"page":"1212-1220","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Assessing the completeness of safety reporting in clinical trials of regional anesthesia interventions: a registry-publication comparison systematic review"],"prefix":"10.1136","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2218-443X","authenticated-orcid":false,"given":"Caitlin","family":"McCormick","sequence":"first","affiliation":[{"name":"Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6997-5503","authenticated-orcid":false,"given":"Danielle","family":"Waller","sequence":"additional","affiliation":[{"name":"Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Elghzali","sequence":"additional","affiliation":[{"name":"Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Logan","family":"Corwin","sequence":"additional","affiliation":[{"name":"Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tag","family":"Harris","sequence":"additional","affiliation":[{"name":"Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Hazlitt","sequence":"additional","affiliation":[{"name":"Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Archer","sequence":"additional","affiliation":[{"name":"Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia I","family":"Ford","sequence":"additional","affiliation":[{"name":"Office of Medical Student Research, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Vassar","sequence":"additional","affiliation":[{"name":"Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"2026100502151101000_51.10.1212.1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bjae.2017.10.002","article-title":"Regional anaesthesia and outcomes","volume":"18","author":"Hutton","year":"2018","journal-title":"BJA Educ"},{"key":"2026100502151101000_51.10.1212.2","unstructured":"Folino TB , Mahboobi SK . Regional anesthetic blocks. In: StatPearls. StatPearls Publishing, 2025."},{"key":"2026100502151101000_51.10.1212.3","doi-asserted-by":"publisher","DOI":"10.1097\/AAP.0000000000000342"},{"key":"2026100502151101000_51.10.1212.4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2147\/LRA.S236550","article-title":"Benefits and Barriers to Increasing Regional Anesthesia in Resource-Limited Settings","volume":"13","author":"Dohlman","year":"2020","journal-title":"Local Reg Anesth"},{"key":"2026100502151101000_51.10.1212.5","first-page":"1232","article-title":"Outcomes research in regional anesthesia and analgesia","volume":"91","author":"Wu","year":"2000","journal-title":"Anesth Analg"},{"key":"2026100502151101000_51.10.1212.6","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1526-4637.2009.00683.x","article-title":"Quality of Reporting of Regional Anesthesia Outcomes in the Literature","volume":"10","author":"Stojadinovic","year":"2009","journal-title":"Pain Med"},{"key":"2026100502151101000_51.10.1212.7","unstructured":"Health and Human Services Department . Clinical trials registration and results information submission. Federal Register. 2016 Available: https:\/\/www.federalregister.gov\/documents\/2016\/09\/21\/2016-22129\/clinical-trials-registration-and-results-information-submission"},{"key":"2026100502151101000_51.10.1212.8","unstructured":"ClinicalTrials.gov . FDAAA 801 and the final rule. Available: https:\/\/clinicaltrials.gov\/policy\/fdaaa-801-final-rule [Accessed 6 Jul 2025]."},{"key":"2026100502151101000_51.10.1212.9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.49.3981"},{"key":"2026100502151101000_51.10.1212.10","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-015-0430-4"},{"key":"2026100502151101000_51.10.1212.11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001566","article-title":"Timing and completeness of trial results posted at ClinicalTrials.gov and published in journals","volume":"10","author":"Riveros","year":"2013","journal-title":"PLoS Med"},{"key":"2026100502151101000_51.10.1212.12","doi-asserted-by":"publisher","DOI":"10.7326\/M13-0480"},{"key":"2026100502151101000_51.10.1212.13","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2026100502151101000_51.10.1212.14","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-025-02486-5","article-title":"Discrepancies in safety reporting for chronic back pain clinical trials: an observational study from ClinicalTrials.gov and publications","volume":"25","author":"Boyne","year":"2025","journal-title":"BMC Med Res Methodol"},{"key":"2026100502151101000_51.10.1212.15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.52.2219"},{"key":"2026100502151101000_51.10.1212.16","unstructured":"Office for Human Research Protections (OHRP) . 45 CFR 46. HHS.gov. 2016. Available: https:\/\/www.hhs.gov\/ohrp\/regulations-and-policy\/regulations\/45-cfr-46\/index.html [Accessed 24 Aug 2025]."},{"key":"2026100502151101000_51.10.1212.17","unstructured":"PROSPERO. Available: https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420251081120 [Accessed 24 Aug 2025]."},{"key":"2026100502151101000_51.10.1212.18","unstructured":"ClinicalTrials.gov . Constructing complex search queries. Available: https:\/\/clinicaltrials.gov\/find-studies\/constructing-complex-search-queries#expansionOp [Accessed 8 Jul 2025]."},{"key":"2026100502151101000_51.10.1212.19","unstructured":"Sign in. Available: https:\/\/osf.io\/swv6u\/ [Accessed 25 Jul 2025]."},{"key":"2026100502151101000_51.10.1212.20","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-031138","article-title":"Selective reporting bias in randomised controlled trials from two network meta-analyses: comparison of clinical trial registrations and their respective publications","volume":"9","author":"Wong","year":"2019","journal-title":"BMJ Open"},{"key":"2026100502151101000_51.10.1212.21","doi-asserted-by":"crossref","first-page":"27762","DOI":"10.1038\/s41598-024-79394-z","article-title":"Safety reporting in trials on glaucoma interventions registered in ClinicalTrials.gov and corresponding publications","volume":"14","author":"Kre\u0161o","year":"2024","journal-title":"Sci Rep"},{"key":"2026100502151101000_51.10.1212.22","unstructured":"Checklist for evaluating whether a clinical trial or study is an applicable clinical trial (act). 2025. Available: https:\/\/cdn.clinicaltrials.gov\/documents\/ACT_Checklist.pdf"},{"key":"2026100502151101000_51.10.1212.23","unstructured":"ELABORATION of definitions of responsible party and applicable clinical trial. 2025. Available: https:\/\/cdn.clinicaltrials.gov\/documents\/ElaborationsOnDefinitions.pdf#:~:text=ELABORATION"},{"key":"2026100502151101000_51.10.1212.24","unstructured":"PART 11\u2014clinical trials registration and results information submission. Available: https:\/\/www.ecfr.gov\/current\/title-42\/chapter-I\/subchapter-A\/part-11 [Accessed 24 Aug 2025]."},{"key":"2026100502151101000_51.10.1212.25","unstructured":"21 USC 360bbb-3a: Emergency use of medical products. Available: https:\/\/uscode.house.gov\/view.xhtml?req=granuleid:USC-prelim-title21-section360bbb-3a&num=0&edition=prelim [Accessed 24 Aug 2025]."},{"key":"2026100502151101000_51.10.1212.26","unstructured":"42 CFR Part 11 -- Clinical Trials Registration and Results Information Submission. Available: https:\/\/www.ecfr.gov\/current\/title-42\/chapter-I\/subchapter-A\/part-11 [Accessed 8 Jul 2025]."},{"key":"2026100502151101000_51.10.1212.27","unstructured":"ClinicalTrials.gov . FDAAA 801 and the final rule. Available: https:\/\/clinicaltrials.gov\/policy\/fdaaa-801-final-rule#intro [Accessed 14 Jul 2025]."},{"key":"2026100502151101000_51.10.1212.28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002127","article-title":"Reporting of Adverse Events in Published and Unpublished Studies of Health Care Interventions: A Systematic Review","volume":"13","author":"Golder","year":"2016","journal-title":"PLoS Med"},{"key":"2026100502151101000_51.10.1212.29","unstructured":"Welcome to. python.org. Available: https:\/\/www.python.org [Accessed 24 Aug 2025]."},{"key":"2026100502151101000_51.10.1212.30","unstructured":"The R Project for Statistical Computing. Available: https:\/\/www.r-project.org [Accessed 24 Aug 2025]."},{"key":"2026100502151101000_51.10.1212.31","unstructured":"The open-source data science company. Posit; 2022. Available: https:\/\/posit.co [Accessed 24 Aug 2025]."},{"key":"2026100502151101000_51.10.1212.32","unstructured":"PROSPERO. Available: https:\/\/www.crd.york.ac.uk\/PROSPERO\/home [Accessed 24 Aug 2025]."},{"key":"2026100502151101000_51.10.1212.33","unstructured":"OSF. Available: https:\/\/osf.io [Accessed 24 Aug 2025]."},{"key":"2026100502151101000_51.10.1212.34","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-005535","article-title":"Differences in reporting serious adverse events in industry sponsored clinical trial registries and journal articles on antidepressant and antipsychotic drugs: a cross-sectional study","volume":"4","author":"Hughes","year":"2014","journal-title":"BMJ Open"},{"key":"2026100502151101000_51.10.1212.35","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g3510"},{"key":"2026100502151101000_51.10.1212.36","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12874-022-01730-6","article-title":"Reporting of the safety from allergic rhinitis trials registered on ClinicalTrials.gov and in publications: An observational study","volume":"22","author":"Paladin","year":"2022","journal-title":"BMC Med Res Methodol"},{"key":"2026100502151101000_51.10.1212.37","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i5078"},{"key":"2026100502151101000_51.10.1212.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2016.07.006"},{"key":"2026100502151101000_51.10.1212.39","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-073725","article-title":"CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials","volume":"381","author":"Junqueira","year":"2023","journal-title":"BMJ"},{"key":"2026100502151101000_51.10.1212.40","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/14740338.2023.2224558","article-title":"Underreporting of Adverse Drug Events: a Look into the Extent, Causes, and Potential Solutions","volume":"22","author":"Al Meslamani","year":"2023","journal-title":"Expert Opin Drug Saf"},{"key":"2026100502151101000_51.10.1212.41","unstructured":"PUBLIC law 110\u201385\u2014sept. 27, 2007. Available: https:\/\/www.govinfo.gov\/content\/pkg\/PLAW-110publ85\/pdf\/PLAW-110publ85.pdf#page=82 [Accessed 14 Jul 2025]."},{"key":"2026100502151101000_51.10.1212.42","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-3022"},{"key":"2026100502151101000_51.10.1212.43","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1016\/j.bja.2021.10.019","article-title":"Adverse event and complication tracking in anaesthesiology: dependence on self-reporting despite implementation of electronic health records","volume":"128","author":"Tewfik","year":"2022","journal-title":"Br J Anaesth"},{"key":"2026100502151101000_51.10.1212.44","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aer407"},{"key":"2026100502151101000_51.10.1212.45","doi-asserted-by":"crossref","first-page":"100085","DOI":"10.1016\/j.jcadva.2024.100085","article-title":"Adverse event reporting in ultrasound-guided brachial plexus blocks: A scoping review","volume":"2","author":"He","year":"2025","journal-title":"JCA Advances"},{"key":"2026100502151101000_51.10.1212.46","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.bja.2025.02.015","article-title":"Discrepancies in adverse event reporting for ketamine trials","volume":"134","author":"Rea","year":"2025","journal-title":"Br J Anaesth"},{"key":"2026100502151101000_51.10.1212.47","unstructured":"Lee S . Clinical trials in anesthesia: a comprehensive guide. Number Analytics LLC. Available: https:\/\/www.numberanalytics.com\/blog\/ultimate-guide-clinical-trials-anesthesia#:~:text=Clinical%20trials%20are%20systematic%20investigations,that%20directly%20impact%20patient%20care [Accessed 21 Jul 2025]."},{"key":"2026100502151101000_51.10.1212.48","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2147\/LRA.S8177","article-title":"Neurological adverse events following regional anesthesia administration","volume":"3","author":"Kent","year":"2010","journal-title":"Local Reg Anesth"},{"key":"2026100502151101000_51.10.1212.49","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)00152-2"},{"key":"2026100502151101000_51.10.1212.50","unstructured":"Policy and Regulation on ClinicalTrials.gov Registration and Reporting, Available: https:\/\/grants.nih.gov\/policy-and-compliance\/policy-topics\/clinical-trials\/reporting\/understanding"},{"key":"2026100502151101000_51.10.1212.51","doi-asserted-by":"crossref","unstructured":"DeVito NJ , Bacon S , Goldacre B . FDAAA trialstracker: a live informatics tool to monitor compliance with fda requirements to report clinical trial results. Clinical Trials [Preprint] 2018. doi:10.1101\/266452 Available: https:\/\/www.biorxiv.org\/content\/10.1101\/266452v4.full","DOI":"10.1101\/266452"},{"key":"2026100502151101000_51.10.1212.52","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)33220-9"},{"key":"2026100502151101000_51.10.1212.53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pctr.0020018","article-title":"When and how can endpoints be changed after initiation of a randomized clinical trial?","volume":"2","author":"Evans","year":"2007","journal-title":"PLoS Clin Trials"},{"key":"2026100502151101000_51.10.1212.54","doi-asserted-by":"crossref","DOI":"10.1111\/jebm.70006","article-title":"Inadequate Reporting of Harm From Randomized Clinical Trials in Top Medical Publications","volume":"18","author":"Zheng","year":"2025","journal-title":"J Evid Based Med"},{"key":"2026100502151101000_51.10.1212.55","unstructured":"Enhancing a culture of safety through disclosure of adverse events. Anesthesia Patient Safety Foundation; 2021. Available: https:\/\/www.apsf.org\/article\/enhancing-a-culture-of-safety-through-disclosure-of-adverse-events\/ [Accessed 22 Jul 2025]."}],"container-title":["Regional Anesthesia &amp; Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rapm-2025-107055","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:15:57Z","timestamp":1791191757000},"score":1,"resource":{"primary":{"URL":"https:\/\/rapm.bmj.com\/lookup\/doi\/10.1136\/rapm-2025-107055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":55,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,5]]},"published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1136\/rapm-2025-107055"],"URL":"https:\/\/doi.org\/10.1136\/rapm-2025-107055","relation":{},"ISSN":["1098-7339","1532-8651"],"issn-type":[{"value":"1098-7339","type":"print"},{"value":"1532-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]}}}